Anlotinib Combined With STUPP for MGMT Nonmethylated Glioblastoma

Clinical trial NCT04725214 · UNKNOWN

Trial details

NCT number: NCT04725214
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

MGMT-Unmethylated Glioblastoma

Start date: 2021-01-15
Primary completion: 2022-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.